Oruka Therapeutics, Inc.
(NASDAQ: ORKA)
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
30.695
-0.235
(-0.76%)
Range
30.515 - 31.800
(4.21%)
Open
31.440
Previous Close
30.930
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
50,234
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 23:07.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
